SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Life Sciences informs about newspaper publication

23 Apr 2026 Evaluate
Suven Life Sciences has enclosed copies of the newspaper advertisement dt. April 23, 2026 published in Business Standard (English) and Nava Telangana (Telugu) regarding Special Window for Re-Lodgment of Transfer Requests of Physical Shares in compliance of SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated 30th January 2026. The above information will also be hosted on the website of the Company at http://www.suven.com/newspaperads.aspx.

The above information is a part of company’s filings submitted to BSE.

Suven Life Sciences Share Price

201.90 -5.65 (-2.72%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×